Is the active ingredient in the medication.
Treatment of impetigo, a common skin infection caused by bacteria.
Treatment of mild to moderate acne.
Prophylaxis of surgical site infections.
Treatment of nasal colonization with Staphylococcus aureus, particularly MRSA (methicillinresistant Staphylococcus aureus).
Biofil Ab Particles (Mupirocin) is a topical antibiotic that works by inhibiting bacterial protein synthesis, specifically by blocking the isoleucine tRNA synthetase enzyme. This prevents bacteria from producing essential proteins necessary for survival and growth, leading to their death.
Store mupirocin at room temperature, between 15-30°C (59-86°F). Protect from light and moisture. Keep out of reach of children.
Apply a thin layer of mupirocin ointment or cream to the affected area 2-3 times daily for 5-10 days.
The exact dosage and duration of treatment may vary depending on the severity of the infection and the individual patient's needs. Consult with a healthcare professional for personalized instructions.
Dryness or scaling of the skin.
Allergic reactions (e.g., rash, hives, swelling).
Skin discoloration.
Increased sensitivity to sunlight.
No known interactions with alcohol.
Mupirocin is unlikely to affect the ability to drive or operate machinery.
The safety of mupirocin during pregnancy and breastfeeding is not fully established. Consult with a healthcare professional to weigh the potential risks and benefits.
Mupirocin is generally safe for use in children, but the dosage and frequency may need to be adjusted based on their age and weight.
Mupirocin is not significantly metabolized by the kidneys. No dosage adjustments are usually required.
Mupirocin is not significantly metabolized by the liver. No dosage adjustments are usually required.
U.S. Food and Drug Administration (FDA): https://www.fda.gov/
National Institutes of Health (NIH): https://www.nih.gov/
Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/
